Last $1.80 USD
Change Today +0.05 / 2.86%
Volume 251.1K
As of 8:10 PM 08/28/14 All times are local (Market data is delayed by at least 15 minutes).

discovery laboratories inc (DSCO) Snapshot

Open
$1.76
Previous Close
$1.75
Day High
$1.83
Day Low
$1.75
52 Week High
10/4/13 - $3.05
52 Week Low
05/9/14 - $1.51
Market Cap
153.4M
Average Volume 10 Days
445.5K
EPS TTM
$-0.66
Shares Outstanding
85.2M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for DISCOVERY LABORATORIES INC (DSCO)

Related News

No related news articles were found.

discovery laboratories inc (DSCO) Related Businessweek News

No Related Businessweek News Found

discovery laboratories inc (DSCO) Details

Discovery Laboratories, Inc., a specialty biotechnology company, focuses on developing life-saving products for critical-care patients with respiratory disease and care in pulmonary medicine. Its drug technology produces a synthetic peptide-containing surfactant (KL4 surfactant), as well as in liquid, lyophilized, and aerosolized dosage forms; and develops drug delivery technologies to enable efficient delivery of its aerosolized KL4 surfactant. The company’s product includes SURFAXIN Intratracheal suspension for the prevention of respiratory distress syndrome (RDS) in premature infants. It is also developing AEROSURF, a drug-device combination product that is in Phase IIa clinical trials for the treatment of RDS in premature infants; and AFECTAIR devices, which are novel disposable aerosol-conducting airway connectors for infants. The company has a strategic alliance with Laboratorios del Dr. Esteve, S.A. for the development, marketing, and sale of KL4 surfactant products in Andorra, Greece, Italy, Portugal, and Spain. Discovery Laboratories, Inc. was founded in 1992 and is headquartered in Warrington, Pennsylvania.

discovery laboratories inc (DSCO) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $493.3K
Chief Operating Officer and Senior Vice Presi...
Total Annual Compensation: $380.3K
Senior Vice President of Research and Develop...
Total Annual Compensation: $336.3K
Senior Vice President, General Counsel and Co...
Total Annual Compensation: $303.5K
Compensation as of Fiscal Year 2013.

discovery laboratories inc (DSCO) Key Developments

Discovery Laboratories Inc. Announces Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2014; Provides Operating Cash Guidance for the Third Quarter of 2014

Discovery Laboratories Inc. announced unaudited consolidated earnings results for the second quarter and six months ended June 30, 2014. For the quarter, the company reported total revenue of $1,093,000, operating loss of $10,942,000 and net loss of $10,623,000 or $0.14 per diluted share against total revenue of $182,000, operating loss of $10,810,000 and net loss of $8,627,000 or $0.22 per diluted share for the same period a year ago. The second quarter operating cash burn was $10.4 million. For the six months, the company reported total revenue of $1,124,000, operating loss of $21,705,000 and net loss of $22,099,000 or $0.28 per diluted share against total revenue of $254,000, operating loss of $23,430,000 and net loss of $21,263,000 or $0.50 per diluted share for the same period a year ago. For the third quarter of 2014, the company forecasting an operating cash burn of approximately $11 million.

Discovery Laboratories Inc., Q2 2014 Earnings Call, Aug 05, 2014

Discovery Laboratories Inc., Q2 2014 Earnings Call, Aug 05, 2014

Discovery Laboratories Inc. to Report Q2, 2014 Results on Aug 05, 2014

Discovery Laboratories Inc. announced that they will report Q2, 2014 results at 9:00 AM, Eastern Standard Time on Aug 05, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
DSCO:US $1.80 USD +0.05

DSCO Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Abbott Laboratories $42.35 USD -0.25
View Industry Companies
 

Industry Analysis

DSCO

Industry Average

Valuation DSCO Industry Range
No financial data is available for DSCO.
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DISCOVERY LABORATORIES INC, please visit www.discoverylabs.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.